Description
Retatrutide 40mg Synedica
The Synedica Retatrutide® 40mg Injection Pen Kit contains 1 pen, 12 disposable needles and an instruction booklet.
Each pen has 40mg which can be delivered across 4 full doses of 10mg, or in increments of 2.5mg, 5mg, 7.5mg or 10mg.
Recommended dosage is 2.5mg for the first 4 weeks, then 5mg for the next 4 weeks. After 8 weeks the weekly dosage may be increased to 7.5mg or 10mg if necessary.
Important Notice
All products are produced exclusively for controlled laboratory research and development applications.
Not for human or animal consumption.
Suitable R&D Applications
Stability Testing
-
Thermal, enzymatic, and oxidative degradation studies
-
Shelf-life evaluation & formulation robustness
Formulation Development
-
Enhances solubility, bioavailability, and structural integrity
-
Tailored for injectable, topical, and research-grade use
Excipient Compatibility Testing
-
Evaluates interactions between peptides & inactive components
-
Ensures safety, stability, and performance
Protease Resistance Evaluation
-
Assesses susceptibility to enzymatic breakdown
-
Supports development of more durable peptide products
Encapsulation & Carrier Systems
-
Liposomes, microspheres, and other delivery vehicles
-
Protects peptides & enables controlled release
Administration Route Assessment
Optimized for:
-
Parenteral delivery (injectables)
-
Dermal absorption (cosmetic/topical)
-
In vitro research applications






Reviews
There are no reviews yet.